This article is part of our Biotech Review of the Year - Issue 12 publication. We help biotech companies to navigate the developing...

This article is part of our Biotech Review of the Year - Issue 12 publication. Following the success of Covid-19 vaccines, the mRNA...

This article is part of our Biotech Review of the Year - Issue 12 publication. It is now over a quarter of a century since the first...

This article is part of our Biotech Review of the Year - Issue 12 publication. On 19 December 2024, the CJEU handed down its decision in...

This article is part of our Biotech Review of the Year - Issue 12 publication. Introduction Denigration – false or misleading statements...

This article is part of our Biotech Review of the Year - Issue 12 publication. The National Security and Investment Act 2021 (NSIA)...

This article is part of our Biotech Review of the Year - Issue 12 publication. It is obvious to many that the biotech and pharma...

This article is part of our Biotech Review of the Year - Issue 12 publication. After years of plans by the UK Government to overhaul the...

This article is part of our Biotech Review of the Year - Issue 12 publication. A note on terminologyIn this article, we use the term AI...

This article is part of our Biotech Review of the Year - Issue 12 publication. The geopolitical, economic and climate crises affecting...

This article is part of our Biotech Review of the Year - Issue 12 publication. How, where and when we work has transformed over the last...

We are thrilled to announce the launch of the 12th edition of our Biotech Review of the Year! 2024 was a remarkable year for biotech,...